JP Patent

JP7023054B2 — レベチラセタム含有医薬組成物及びその製造方法

Assigned to Towa Pharmaceutical Co Ltd · Expires 2022-02-21 · 4y expired

What this patent protects

Patent listed against raltegravir-potassium.

Drugs covered by this patent

raltegravir-potassium (RALTEGRAVIR POTASSIUM)

Patent Metadata

Patent number: JP7023054B2
Jurisdiction: JP
Classification: —
Expires: 2022-02-21
Drug substance claim: No
Drug product claim: No
Assignee: Towa Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.